Multicenter Phase II Study of Border Zone Stereotactic Radiosurgery With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Multiforme
Phase of Trial: Phase II
Latest Information Update: 09 May 2019
Price : $35 *
At a glance
- Drugs Bevacizumab (Primary)
- Indications Glioblastoma
- Focus Therapeutic Use
- 02 Apr 2019 Status changed from active, no longer recruiting to completed.
- 05 Feb 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Aug 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2020.